No Data
No Data
No Data
No Data
No Data
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine
By Chris Wack Imunon shares rose after the company received clearance from the U.S. Food and Drug Administration to begin a Phase 1 clinical trial with a seasonal Covid-19 booster vaccine. Shares we
WSJApr 18 22:23
IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101
PDF Version Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarterLAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IM
ImunonApr 18 12:00
IMUNON Reports Compliance With Nasdaq Listing Requirements
PDF Version LAWRENCEVILLE, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) ("IMUNON" or the "Company"), a clinical-stage drug-development company focused on developing DNA-
ImunonApr 11 12:00
Imunon Withdraws Filing for Securities Offering
Imunon Withdraws Filing for Securities Offering
Dow JonesApr 11 04:11
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
BenzingaApr 5 20:09
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million. Aesthetic Medical Intl (N
BenzingaApr 3 04:31
No Data
No Data